InsidersTradesSigma
Track the 漢田生技 share price and the full management transaction log of the company, a listed equity based in Taiwan. Shares are listed on the TW market, under the oversight of TWSE / TPEx (MOPS). Market capitalisation: €2bn. The latest transaction was filed on 17 June 2026 (Negotiated). Among the most active insiders: 曾士哲. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
漢田生技是一家在 XTAI 市场上市的公司，专注于生物技术领域。它致力于开发医疗保健领域的创新解决方案。